سمتهای علمی و اجرایی در دانشگاهها و مراکز علمی کشور
سمتهای علمی و اجرایی در مجلات و ژورنالهای معتبر ایران
ISI Papers
- "Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review", Maad Rayan Publishing Company, (2017), Vol 6, No 3: 254-263
- "New Methods in Treatment of Renal Failure in Patients with Multiple Myeloma : A Review with Immunological Approach", Medi + World International, (2017), Vol 15, No 7: 95-103
- "A new approach for treatment of type 1 diabetes: Phytotherapy and phytopharmacology of regulatory T cells", Maad Rayan Publishing Company, (2017), Vol 6, No 3: 158-163
- "Survivin as a diagnostic and therapeutic marker for thyroid cancer", Elsevier BV, (2019), Vol 215, No 4: 619-625
- "MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma", AME Publishing Company, (2019), Vol 10, No 4: 789-796
- "COVID-19 Pandemic along with Pandemic of Lifestyle-Associated Diseases Victimizes Patients in an Inflammation Context!", S. Karger AG, (2020), Vol 3, No 2: 55-57
- "Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19", Informa UK Limited, (2021), Vol 43, No 3: 247-258
- "miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19", Springer Science and Business Media LLC, (2021), Vol 394, No 11: 2187-2195
- "COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?", Wiley, (2020), Vol 128, No 1: 37-45
- "Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?", Springer Science and Business Media LLC, (2021), Vol 394, No 5: 997-1001
- "Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial", Elsevier BV, (2022), Vol 53, No 4: 368-377
- "Evaluating serum levels of interleukin-8 and interleukin-17 in patients with COVID-19 and their correlation with disease severity", Maad Rayan Publishing Company, (2022), Vol , No :
- "Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial", Elsevier BV, (2022), Vol 53, No 1: 79-85
- "Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials", Central Research Institute for Epidemiology, (2022), Vol 67, No 2: 126-132